Observational Study of Gastroparesis Treatments

This is an observational study called GOLDEN that collects information from people with gastroparesis (a condition where your stomach empties too slowly). Researchers are looking at how different treatments affect symptoms, survival, and quality of life over time. These treatments include GI Neuromodulation (like gastric electrical stimulation, or GES), Immunotherapy (like Intravenous Immunoglobulin), and Pyloric therapies (like pyloroplasty). You might be able to join if you have gastroparesis symptoms that haven't improved with other medicines, have nutrition problems, and can describe your current symptoms. You cannot join if you have a blockage in your digestive system, are pregnant, or have certain psychiatric disorders. The study is ongoing and aims to include 3000 participants.

Study design
This is an observational study, meaning researchers will collect information about your health and treatments over time. It is not a clinical trial where you receive a new treatment.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms will be followed from when you start the study up to one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03876288

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

Recruiting
Not specifiedAll AgesObservational
University of Louisville
~3,000 participants
Updated 2026-04-20 on ClinicalTrials.gov
What's tested:GI NeuromodulationImmunotherapyPyloric Therapies

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Reported Outcome GI Symptoms
Measured over Change from baseline to one week to one year
Gastroparesis
1 sites across 1 states
Kentucky1
  • Thomas Abell, MD · PRINCIPAL_INVESTIGATOR · University of Louisville

Opens a ready-to-send draft in your own email app — review before sending.

  • Patient Reported Outcome GI SymptomsChange from baseline to one week to one year

    The primary outcome measures are patient symptoms via the traditional gastroparesis patient reported outcome scale. It uses a 0-4 scale from none to worse on GI Symptoms; for example: Nausea,Vomiting, Anorexia/Early Satiety, Bloating/distension, Abdominal Pain. Scored as each item plus a total that is the sum of the individual scales.The five Sx subscales of 0-4 each are summed for a total score range 0-20